Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Get the latest international news and world events from around the world.

Log in for authorized contributors

Is This The End of OpenAI?

Elon Musk’s lawsuit against OpenAI aims to expose the company’s alleged abandonment of its non-profit mission and potential shift to a for-profit model, sparking a heated dispute over the company’s future and integrity ##

## Questions to inspire discussion.

Understanding the lawsuit timeline and stakes.

🔍 Q: When is Elon Musk’s lawsuit against OpenAI going to trial and what is he claiming?

A: The lawsuit is set to go to trial in April 2026, with Musk arguing he’s owed billions from the value of intellectual property developed from his contributions as the primary funder who wanted OpenAI to remain nonprofit and open source.

📄 Q: What evidence exists in Greg Brockman’s personal files from 2017?

Continue reading “Is This The End of OpenAI?” | >

Why does AI being good at math matter?

This is the second time in recent months that the AI world has got all excited about math. The rumor mill went into overdrive last November, when there were reports that the boardroom drama at OpenAI, which saw CEO Sam Altman temporarily ousted, was caused by a new powerful AI breakthrough. It was reported that the AI system in question was called Q* and could solve complex math calculations. (The company has not commented on Q*, and we still don’t know if there was any link to the Altman ouster or not.) I unpacked the drama and hype in this story.

You don’t need to be really into math to see why this stuff is potentially very exciting. Math is really, really hard for AI models. Complex math, such as geometry, requires sophisticated reasoning skills, and many AI researchers believe that the ability to crack it could herald more powerful and intelligent systems. Innovations like AlphaGeometry show that we are edging closer to machines with more human-like reasoning skills. This could allow us to build more powerful AI tools that could be used to help mathematicians solve equations and perhaps come up with better tutoring tools.

Detecting single-electron qubits: Microwaves could probe quantum states above liquid helium

One intriguing method that could be used to form the qubits needed for quantum computers involves electrons hovering above liquid helium. But it wasn’t clear how data in this form could be read easily.

Now RIKEN researchers may have found a solution. Their work is published in the journal Physical Review Letters.

IgG2c subclass dominance drives fatal lupus-like nephritis via FcγR and complement activation

Luan et al. establish the first mouse model that develops spontaneous, fully penetrant, and rapid-onset glomerulonephritis, demonstrating that dominant expression of an activating IgG subclass is sufficient to drive lethal lupus-like nephritis.

Lymph Node Dissection Guidelines and Survival in Lung Adenocarcinoma

Guideline-adherent lymph node dissection provided a small survival benefit for patients with high-grade or no lepidic pattern LungAdenocarcinoma, but not for those with lepidic pattern alone.

Importance Lymph node dissection for early-stage lung adenocarcinoma is controversial. Histologic pattern subtyping reveals heterogeneity of lung adenocarcinoma, yet its association with lymph node involvement and dissection is understudied.

Objective To assess the association between guideline-adherent lymph node dissection, histologic pattern subtyping, and overall survival in patients with clinical T1N0M0 lung adenocarcinoma.

Design, Setting, and Participants This multicenter cohort study used data from the National Cancer Center LungReal database, a multicenter, electronic health records-based database for patients undergoing surgery for lung cancer, from January 2014 to December 2021, with the last follow-up in December 2022. Patients were categorized based on histologic pattern of adenocarcinoma into 2 groups: lepidic without high-grade pattern, and high-grade or no lepidic pattern. The data analysis was performed from April to November 2025.

New “Cancer Flashlight” Could Reveal Who Truly Benefits From Targeted Treatments

A University of Missouri scientist develops a cancer “flashlight” that helps identify which patients are most likely to respond to targeted therapies. To better understand which patients may respond to targeted cancer therapies, a University of Missouri researcher is developing a new way to make

Immune-targeting vaccine shows promise intercepting cancer in patients with Lynch Syndrome

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and cancerous cells in individuals with Lynch Syndrome (LS), according to a study from researchers at The University of Texas MD Anderson Cancer Center.

The results of a Phase Ib/II clinical trial, published today in Nature Medicine, provide early evidence that immune-based approaches, such as NOUS-209, may be able to intercept cancer before it develops, offering a potential new avenue for preventive care for high-risk individuals.

“Current management strategies for Lynch Syndrome patients—frequent screenings or elective preventive surgery—are life-changing interventions that help prevent cancer development but can significantly affect quality of life,” said principal investigator Eduardo Vilar-Sanchez, M.D., Ph.D., chair ad interim of Clinical Cancer Prevention. “By teaching the immune system to recognize and attack abnormal cells, this therapy offers a promising new approach to this patient population, who face a significantly higher risk of colorectal, endometrial, urothelial and other cancers.”

/* */